These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 10677922

  • 21. Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan.
    Hsueh PR, Wu JJ, Lu JJ, Teng LJ, Luh KT.
    J Formos Med Assoc; 1999 Jan; 98(1):45-8. PubMed ID: 10063273
    [Abstract] [Full Text] [Related]

  • 22. [Drug resistance of 100 clinical strains of Enterococcus spp].
    Sawicka-Grzelak A, Rokosz A, Luczak M.
    Med Dosw Mikrobiol; 1999 Jan; 51(3-4):239-47. PubMed ID: 10803253
    [Abstract] [Full Text] [Related]

  • 23. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L.
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [Abstract] [Full Text] [Related]

  • 24. Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin.
    Fuller RE, Drew RH, Perfect JR.
    Pharmacotherapy; 1996 May; 16(4):584-92. PubMed ID: 8840364
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
    Ristow TA, Noskin GA, Warren JR, Peterson LR.
    Microb Drug Resist; 1995 May; 1(4):335-9. PubMed ID: 9158806
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
    Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):163-70. PubMed ID: 17368801
    [Abstract] [Full Text] [Related]

  • 27. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB, Fernandes LA, Fernandes CJ.
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [Abstract] [Full Text] [Related]

  • 28. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
    Kowalski RP, Karenchak LM, Warren BB, Eller AW.
    Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
    [Abstract] [Full Text] [Related]

  • 29. Enterococcus faecium isolated from bone marrow transplant patients in Tunisia: high prevalence of antimicrobial resistance and low pathogenic power.
    Abbassi MS, Achour W, Touati A, Ben Hassen A.
    Pathol Biol (Paris); 2009 May; 57(3):268-71. PubMed ID: 18394823
    [Abstract] [Full Text] [Related]

  • 30. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent.
    Karanika M, Prati A, Kiritsi M, Spiliopoulou I, Neonakis I, Anifantaki M, Petinaki E.
    Int J Antimicrob Agents; 2008 Jan; 31(1):55-7. PubMed ID: 17923393
    [Abstract] [Full Text] [Related]

  • 31. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Emerging vancomycin resistance in enterococci in India.
    Ghoshal U, Garg A, Tiwari DP, Ayyagari A.
    Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin.
    Zervos M.
    New Horiz; 1996 Aug; 4(3):385-92. PubMed ID: 8856757
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Quinupristin/dalfopristin: a treatment option for vancomycin-resistant Enterococci.
    Kim MK, Nicolau DP, Nightingale CH, Quintiliani R.
    Conn Med; 2000 Apr; 64(4):209-12. PubMed ID: 10812767
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.